The TRACK-HD study in 2009 used multi-site MRI to show quantifiable biological and clinical alternation in Huntingtin mutation carriers compared with age-matched controls demonstrating the feasibility of using this technique to detect Huntington's disease. This evidence concerns the gene HTT and Huntington disease.